Keyphrases
Cancer Treatment
20%
Cas9 Protein
20%
Cell Response
20%
Chemoattraction
20%
Chemotherapy Resistance
20%
Differential Enrichment
20%
Driver mutations
20%
Enrichment Pattern
20%
Genetic Engineering
20%
Genetic Parameters
20%
Genome Editing
20%
Glioblastoma
100%
Glioblastoma Cells
20%
Glioma Model
40%
Growth Resistance
20%
Hepatocellular Carcinoma
40%
Hypoxia
20%
Immune Cells
20%
Incomplete Understanding
20%
Infiltration
20%
Mesenchymal Transition
20%
Monocyte Chemoattractant protein-1 (MCP-1)
20%
Monocyte Depletion
100%
Monocyte Infiltration
20%
Monocytes
100%
Mouse Model
20%
Murine Model
20%
Myeloid Cells
40%
Neutrophil Influx
100%
Neutrophils
100%
Platelet-derived Growth factor-BB (PDGF-BB)
80%
Primary Glioblastoma
20%
Proneural-mesenchymal Transition
100%
Single-cell RNA Sequencing (scRNA-seq)
20%
Therapeutic Design
20%
Therapeutic Intervention
20%
Tumor
20%
Tumor Genotyping
20%
Tumor Growth
20%
Tumor Necrosis Factor-α
20%
Tumor Subtype
20%
Tumor Therapeutics
20%
Tumor-bearing Mice
20%
Biochemistry, Genetics and Molecular Biology
CRISPR/Cas9
25%
Genetics
25%
Genome Editing
25%
Genotyping
25%
Immunocompetent Cell
25%
Mouse Model
25%
Murine
25%
Myeloid
50%
Platelet Derived Growth Factor B
100%
RNA Sequence
25%
Tumor Necrosis Factor
25%
Tumor Progression
25%
Immunology and Microbiology
CRISPR/Cas9
14%
Gene Editing
14%
Immunocompetent Cell
14%
Monocyte Chemotactic Protein
14%
Mouse Model
14%
Murine
14%
Myeloid
28%
Neutrophil
100%
Platelet Derived Growth Factor B
57%
RNA Sequence
14%
Tumor Necrosis Factor
14%